Creating new drugs and therapies for diseases
Drug Design and Synthesis Core
This study is all about helping scientists create new medicines by exploring different biological targets and making new chemical versions of drugs, so they can find better treatments for tough diseases.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of South Carolina at Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project ID | NIH-10936196 on NIH RePORTER |
What this research studies
The Drug Design and Synthesis Core (DDSC) focuses on evaluating biological targets to determine their potential for drug development. It assists researchers in synthesizing chemical analogs that can be used in creating new medications. By providing expertise in drug discovery and optimization strategies, the DDSC aims to facilitate the development of innovative therapeutic options for various challenging diseases. This core facility is unique to the University of South Carolina and plays a crucial role in advancing biomedical research.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that currently lack effective treatment options.
Not a fit: Patients with well-established treatment protocols for their conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and effective treatments for various diseases.
How similar studies have performed: Other research initiatives in drug design and synthesis have shown promise in developing new therapies, indicating a strong potential for success in this area.
Where this research is happening
Columbia, United States
- University of South Carolina at Columbia — Columbia, United States (Active)
Researchers
- Principal investigator: Mcinnes, Campbell — University of South Carolina at Columbia
- Study coordinator: Mcinnes, Campbell
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.